Eunpi Cho , Joshua Schiffer , Kathleen Murphy , B. Douglas Smith
{"title":"孤立性粒细胞肉瘤:三例罕见病例报告及回顾","authors":"Eunpi Cho , Joshua Schiffer , Kathleen Murphy , B. Douglas Smith","doi":"10.3816/CLK.2008.n.039","DOIUrl":null,"url":null,"abstract":"<div><p>Granulocytic sarcomas are rare, extramedullary tumors composed of immature myeloid cells. Traditionally, these tumors present in patients with known leukemias; however, granulocytic sarcomas may present as an isolated finding in patients without known disease. As such, isolated granulocytic sarcomas may present a diagnostic challenge for clinicians taking care of the patient. Moreover, these tumors also create a therapeutic challenge for clinicians as they generally carry a poor prognosis and often have short-lived responses to systemic therapy with cytarabine-based chemotherapy. An improved understanding of the biology of granulocytic sarcomas may reveal targets accessible to some of the new biologically active agents being studied across oncology. This report of 3 usual presentations of granulocytic sarcomas and a brief review of the known pathophysiology reminds us that there is much work to do to improve outcomes for our patients.</p></div>","PeriodicalId":100271,"journal":{"name":"Clinical Leukemia","volume":"2 4","pages":"Pages 275-279"},"PeriodicalIF":0.0000,"publicationDate":"2008-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3816/CLK.2008.n.039","citationCount":"0","resultStr":"{\"title\":\"Isolated Granulocytic Sarcoma: Case Reports of Three Rare Presentations and Review\",\"authors\":\"Eunpi Cho , Joshua Schiffer , Kathleen Murphy , B. Douglas Smith\",\"doi\":\"10.3816/CLK.2008.n.039\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Granulocytic sarcomas are rare, extramedullary tumors composed of immature myeloid cells. Traditionally, these tumors present in patients with known leukemias; however, granulocytic sarcomas may present as an isolated finding in patients without known disease. As such, isolated granulocytic sarcomas may present a diagnostic challenge for clinicians taking care of the patient. Moreover, these tumors also create a therapeutic challenge for clinicians as they generally carry a poor prognosis and often have short-lived responses to systemic therapy with cytarabine-based chemotherapy. An improved understanding of the biology of granulocytic sarcomas may reveal targets accessible to some of the new biologically active agents being studied across oncology. This report of 3 usual presentations of granulocytic sarcomas and a brief review of the known pathophysiology reminds us that there is much work to do to improve outcomes for our patients.</p></div>\",\"PeriodicalId\":100271,\"journal\":{\"name\":\"Clinical Leukemia\",\"volume\":\"2 4\",\"pages\":\"Pages 275-279\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.3816/CLK.2008.n.039\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Leukemia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1931692513600455\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1931692513600455","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Isolated Granulocytic Sarcoma: Case Reports of Three Rare Presentations and Review
Granulocytic sarcomas are rare, extramedullary tumors composed of immature myeloid cells. Traditionally, these tumors present in patients with known leukemias; however, granulocytic sarcomas may present as an isolated finding in patients without known disease. As such, isolated granulocytic sarcomas may present a diagnostic challenge for clinicians taking care of the patient. Moreover, these tumors also create a therapeutic challenge for clinicians as they generally carry a poor prognosis and often have short-lived responses to systemic therapy with cytarabine-based chemotherapy. An improved understanding of the biology of granulocytic sarcomas may reveal targets accessible to some of the new biologically active agents being studied across oncology. This report of 3 usual presentations of granulocytic sarcomas and a brief review of the known pathophysiology reminds us that there is much work to do to improve outcomes for our patients.